Saitama-ken, Japan

Akiko Shingai


Average Co-Inventor Count = 7.8

ph-index = 3

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 1998-2005

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Akiko Shingai

Introduction

Akiko Shingai, a distinguished inventor based in Saitama-ken, Japan, has made significant contributions to the field of biochemistry and pharmaceuticals. With a remarkable portfolio of eight patents, her work primarily focuses on cyclic depsipeptides and their applications in medical therapies.

Latest Patents

Among her latest patents are innovative formulations of cyclic depsipeptides. These compounds feature a comprehensive structure where R comprises a straight or branched alkyl group with 5-20 carbon atoms or a straight or branched alkoxymethyl group with 5-15 carbon atoms. Components A, B, D, E, and F can vary and include essential amino acids such as alanine, valine, leucine, isoleucine, and phenylalanine. The present inventions hold remarkable therapeutic potential, including promoting the production of apolipoprotein E and serving as treatment agents for neurologic damages, dementia, and hyperlipemia. Another notable patent includes depsipeptides incorporating N-substituted glycine residues, showcasing her expertise in peptide synthesis.

Career Highlights

Throughout her career, Akiko Shingai has been affiliated with prominent companies including Nisshin Flour Milling Co., Ltd. and Nisshin Seifun Group Inc. Her work in these organizations has enabled her to bridge the gap between theoretical research and practical applications in the biopharmaceutical industry.

Collaborations

In her journey as an inventor, Akiko has collaborated with esteemed colleagues, including Shigeru Hiramoto and Makoto Yanai. These professional partnerships have reinforced her innovative endeavors and contributed to the successful development of her patent portfolio.

Conclusion

Akiko Shingai stands out as a leading inventor, leveraging her extensive knowledge and collaborative spirit to advance the field of biochemistry. Her contributions, particularly in the development of cyclic depsipeptides, continue to pave the way for new therapeutic agents that may significantly impact neurology and metabolic disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…